Synsam AB (publ) Stock: price and insider trades · Sweden

Every trade that managers of Synsam AB (publ) disclose to Finansinspektionen is tracked on this page. The company sits in the Healthcare & Pharma sector. Between 18 October 2025 and 18 October 2026, 15 insiders published 24 filings.

On the market, 3 insiders bought (4 purchases totalling €160k) while 5 insiders sold (5 sales totalling €382k). Taken together, the sales exceed the purchases by €222k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 1 board member, 1 senior executive and 1 chief executive. One trade stands out by size: a sale of €182k from Kåre Olav Torgersen, disclosed on 11 June 2026, or 0.025% of market capitalisation.

Within a 30-day window, 1 purchase overlapped with buying by a second insider. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The clock since the last published purchase (13 May 2026) now reads 158 days. The median gap between a trade and its publication by Finansinspektionen is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

With 24 filings in twelve months, the company is more active than the median of 7 filings across the 890 companies we follow on the same exchange. Over the whole record (from 2025), the tally stands at 19 purchases and 5 sales.

Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.